Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: a systematic review

Cespiati, Annalisa; Rodrigues, Inês Coelho; Santos, Inês; Policarpo, Sara; Carvalhana, Sofia; Fracanzani, Anna Ludovica; Cortez-Pinto, Helena

http://hdl.handle.net/10451/64667

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Effect_HCV.pdf		924.23 KB	Adobe PDF	Download

Send Feedback

Authors

Cespiati, Annalisa

Rodrigues, Inês Coelho

Santos, Inês

Policarpo, Sara

Carvalhana, Sofia

Fracanzani, Anna Ludovica

Cortez-Pinto, Helena

Abstract(s)

Background and Aims The beneficial effect of Hepatitis C virus (HCV) eradication by direct antiviral agents (DAAs) on liver fibrosis is well defined. Despite this, the impact of viral eradication in both hepatic and extra-hepatic metabolic features is underreached. This systematic review aimed to synthesize the evidence on the impact of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, glucidic impairment, dyslipidaemia, and weight gain. Methods A systematic search of the existing literature (up to December 2022) identified 97 original studies that fulfilled the inclusion criteria. Results Whereas total cholesterol and low-density lipoprotein (LDL) seem to increase after viral eradication, the cardiovascular damage expressed as carotid plaques and intima-media thickness seems to improve. Otherwise, the effect on liver steatosis, glucidic homeostasis, and weight seems to be strictly dependent on the presence of baseline metabolic disorders. Conclusion Despite high heterogeneity and relatively short follow-up of included studies, we can conclude that the presence of metabolic risk factors should be strictly evaluated due to their impact on liver steatosis, glucidic and lipid homeostasis, and on weight gain to better identify patients at risk of liver disease progression despite the virus eradication.

Description

© 2024 The Authors. Liver International published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.